2.3 million Dollar funding for HIV vaccine development: RUB researchers want to trick immune system
A new approach to HIV vaccine development
RUB-medical researchers want to trick the immune system
2.3 million Dollar funding from the Bill & Melinda Gates Foundation
To support their research for a vaccine against the HI-Virus, Prof. Dr. Klaus Überla of the Faculty for Medicine at the Ruhr-Universität Bochum and his research team will receive $2.3 million in funding within the next three years from the Bill & Melinda Gates Foundation. The scientists are part of the Collaboration for AIDS Vaccine Discovery (CAVD), which seeks to speed up the development of an HIV-vaccine through a rigorous exchange of information, methods and reagents.
“The project rests upon our observation that certain immunological reactions seem to increase the risk of HIV-infection,” Prof. Überla said. “We want to avoid these kinds of harmful immune system responses while still creating protective antibodies.”
Earlier study: HIV-vaccine increases risk of infection
Prior attempts to develop vaccines against HIV have not been successful. The preparation that was used in the Merck Pharmacy’s so-called STEP study actually increases HIV susceptibility. “It is extraordinarily important to understand why the vaccine has this effect,” Überla said. “These findings could have an enormous impact on the development of future substances.” By building on the findings of the STEP study, the research team plans to develop a new vaccine that will undergo in vivo testing.
T helper cells: HIV-proliferation vs. antibody production
Earlier studies have shown that certain antibodies against the envelope proteins of HIV could protect from HIV infection. Important for such antibody production are the CD4 T helper cells. Different kinds of these T helper cells recognize different pathogens in the body and signal other cells to create the appropriate antibodies in response to the invasive microorganisms. However, reactive CD4 T helper cells are also where HIV multiples particularly quickly. Therefore, if the number of HIV-responsive CD4 T helper cells increases as a result of the vaccine, the effect is simultaneously helpful and hurtful.
Helping, not hurting
The aim of the research project “Induction of affinity-matured HIV Env antibodies in the absence of HIV-specific T helper cells” is to investigate a new immunization method. Scientists associated with the project want to produce HIV antibodies through the use of T helper cells whose purpose is the recognition of other pathogens, rather than those which recognize the presence of HIV. This would mean that the number of T helper cells which respond to HIV would not go up through vaccination, thereby making it more difficult for HIV to multiply. The effectiveness of this new immunization method will be determined in cooperation with Dr. Stahl-Henning of the German Primate Center in Göttingen.
Prof. Dr. Klaus Überla, Department for Molecular and Medical Virology, Faculty for Medicine, Ruhr-Universität, 44780 Bochum, Germany, Phone: +49/234/32-23189
Click for more
Collaboration for AIDS Vaccine Discovery
Editor: Dr. Julia Weiler
Dr. Josef König | idw
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
A study carried out by an international team of researchers and published in the journal Physical Review X shows that ion-trap technologies available today are suitable for building large-scale quantum computers. The scientists introduce trapped-ion quantum error correction protocols that detect and correct processing errors.
In order to reach their full potential, today’s quantum computer prototypes have to meet specific criteria: First, they have to be made bigger, which means...
German and Spanish researchers plan, build and use modern spectrograph
Since 2016, German and Spanish researchers, among them scientists from the University of Göttingen, have been hunting for exoplanets with the “Carmenes”...
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Detailed calculations show water cloaks are feasible with today's technology
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...